Erythromycin is a macrolide antibiotic used for selected bacterial infections in adults and children. It blocks bacterial protein production and can also stimulate gut motilin receptors in carefully…
Erythromycin is a macrolide antibiotic used for selected bacterial infections in adults and children. It blocks bacterial protein production and can also stimulate gut motilin receptors in carefully selected gastrointestinal conditions.
Erythromycin, the active ingredient in Erythromycin, is a macrolide antibiotic for selected bacterial infections in adults and children.
The amount per intake is set individually for each person rather than being one fixed number. The schedule depends on the infection, age, body weight, kidney and liver function, formulation, and local prescribing guidance.
Typical administration principles include:
A course that is stopped as soon as symptoms improve may leave surviving bacteria behind. Skipping doses can also make it harder to judge whether the antibiotic is working.
Erythromycin is the active ingredient in this product. It belongs to the macrolide antibiotic class and limits bacterial protein synthesis by binding to bacterial ribosomes. It may also stimulate gut motilin receptors in carefully selected gastrointestinal conditions.
Erythromycin attaches to the 50S subunit of susceptible bacterial ribosomes. This prevents the ribosome from producing proteins needed for bacterial growth. Its antibacterial action is often bacteriostatic, although activity can be bactericidal against some organisms at suitable concentrations.
The same molecule has a separate gastrointestinal action. By stimulating motilin receptors, it can increase antral contractions and gastric emptying. This explains why nausea, cramps, and diarrhoea can occur during antibiotic treatment, even when the infection itself is improving.
WHO antibiotic guidance supports using antibiotics according to the likely pathogen and local resistance information rather than choosing solely by drug class [2].
Erythromycin belongs to the macrolide antibiotic class. It binds to bacterial ribosomes and limits protein synthesis, which slows or stops the growth of susceptible organisms. Doctors may prescribe it for respiratory infections, selected skin conditions, and some infections caused by organisms that respond poorly to other antibiotic classes [1].
Erythromycin is not useful for viral illnesses such as ordinary colds or influenza. The choice depends on the suspected organism, infection site, local resistance patterns, allergy history, and the person’s other medicines.
| Body system | Examples of clinical use | Key pharmacological point |
|---|---|---|
| Respiratory | Strep Throat, Whooping Cough, bacterial pneumonia, acute bacterial infection of the sinuses | Macrolide activity against selected bacteria |
| Skin | Acne and selected Skin Infection | Use depends on bacterial susceptibility and treatment site |
| Gastrointestinal | Stomach Muscle Paralysis and Decreased Function in selected specialist situations | Motilin-receptor stimulation may increase gastric movement |
Erythromycin may be used for Strep Throat caused by susceptible streptococci, especially when a clinician needs a macrolide option. It has also been used in Whooping Cough, the respiratory infection caused by Bordetella pertussis. Treatment can reduce bacterial carriage and may limit transmission when started at an appropriate stage.
Bacterial pneumonia requires clinical assessment because pneumonia can worsen quickly and may need a different antibiotic, imaging, or hospital care. Erythromycin may cover selected respiratory pathogens, yet it is not the correct choice for every case.
Acute bacterial infection of the sinuses is treated with antibiotics only when the clinical pattern supports bacterial disease. Coloured nasal discharge alone does not prove a bacterial infection. A prescriber considers symptom duration, severity, fever, facial pain, and the risk of complications.
Erythromycin has been used for Acne and selected Skin Infection when susceptible bacteria contribute to inflammation or infection. Topical and oral treatment are different clinical approaches, so a tablet should not be assumed to replace a topical preparation.
Erythromycin also activates motilin receptors. This action can increase upper gastrointestinal contractions and has led to specialist use in Stomach Muscle Paralysis and Decreased Function, including selected cases of delayed gastric emptying. This use differs from antibiotic treatment and may involve a short course under medical supervision because the effect can diminish with repeated exposure.
Several practical errors can reduce treatment quality or increase side effects:
A missed dose does not usually justify doubling the next intake. If several doses have been missed, the prescriber or dispensing pharmacist may need to decide whether the course should be adjusted.
Erythromycin may not be suitable for you if any of the following applies:
Erythromycin strongly inhibits CYP3A4, an enzyme involved in the breakdown of many medicines. Important interaction groups include certain statins, some antiarrhythmics, selected calcium-channel blockers, anticoagulants, anticonvulsants, immunosuppressants, and medicines used for migraine or erectile dysfunction. The exact combination matters.
Erythromycin can increase exposure to simvastatin and related medicines, raising the risk of muscle injury. It can also increase the effects of warfarin, making bleeding more likely and requiring closer monitoring when a prescriber considers the combination.
Tell the prescriber about heart disease, fainting, liver disease, previous antibiotic-associated colitis, pregnancy, breastfeeding, and every prescription, over-the-counter medicine, and supplement in use.
Pregnancy and breastfeeding require an individual assessment. Erythromycin has been used during pregnancy when treatment is clinically indicated, but the infection, formulation, timing, and alternatives all matter. Small amounts can pass into breast milk and may cause diarrhoea or irritability in an infant.
Gastrointestinal reactions are the side effects patients report most often. Erythromycin can cause stomach pain, nausea, vomiting, abdominal cramping, and diarrhoea because of both local gastrointestinal irritation and motilin-receptor activity.
Rash can occur as a hypersensitivity reaction. Thrush may develop after antibiotic exposure because changes in normal bacterial flora can allow yeast to multiply. Hair loss is not among the usual reactions, but unusual hair shedding should still be reported if it appears during treatment or persists afterwards.
Common or clinically recognised reactions include:
Seek urgent medical attention for facial swelling, breathing difficulty, fainting, a rapidly spreading blistering rash, yellowing of the skin, or severe diarrhoea with blood or fever. These symptoms can indicate a serious allergic, hepatic, cardiac, or intestinal reaction.
Erythromycin can prolong the QT interval, a measurement of the heart’s electrical recovery between beats. The risk rises with certain heart conditions, low potassium or magnesium, and other QT-prolonging medicines. The FDA prescribing information describes this risk and lists important interaction restrictions [3].
One practical detail is easy to miss: severe diarrhoea can begin during treatment or weeks after the last pill. Avoid self-treating persistent diarrhoea with anti-motility products until antibiotic-associated colitis has been considered.
Erythromycin and Penicillin are different antibiotic classes. Penicillin is a beta-lactam that interferes with bacterial cell-wall construction, while erythromycin inhibits bacterial protein synthesis.
| Feature | Erythromycin | Penicillin |
|---|---|---|
| Drug class and mechanism | Macrolide; blocks the 50S ribosome | Beta-lactam; disrupts bacterial cell-wall synthesis |
| Selection factors | Useful for selected susceptible infections and some beta-lactam allergy situations; interaction and rhythm risks matter | Often preferred when the organism is susceptible and there is no relevant allergy |
Penicillin may be preferred for some streptococcal infections because it has a narrower spectrum and established clinical performance. Erythromycin may be considered when a patient has a documented immediate beta-lactam allergy or when its activity better matches the suspected organism.
Resistance can limit either option. A penicillin allergy label should be reviewed carefully because an inaccurate label can lead to broader-spectrum antibiotics, more interactions, and more adverse effects. The European Medicines Agency highlights the need to balance antimicrobial selection with safety and resistance concerns [4].
In clinical practice, doctors usually judge erythromycin by the response of the infection, not by symptom relief after the first pill. Fever and pain may improve before the bacterial process has fully resolved. A lack of improvement, deterioration, or a new focal symptom can mean that the diagnosis, organism, or antibiotic needs reassessment.
Clinicians also review the reason for choosing a macrolide. A documented penicillin allergy may support erythromycin, but a vague childhood history of “penicillin allergy” deserves clarification when time allows. The allergy type changes the available options.
Doctors pay close attention to drug interactions. Erythromycin is not a routine add-on antibiotic for people taking multiple heart medicines, cholesterol medicines, or anticoagulants. A clinical pharmacology review indexed in PubMed describes macrolide interaction pathways and the need for medication reconciliation before treatment [5].
Yes. Stomach pain, nausea, vomiting, and diarrhoea are recognised adverse effects of Erythromycin, partly because the drug stimulates motilin receptors in the gastrointestinal tract. Medsafe's 2022 safety information describes gastrointestinal intolerance among the reactions associated with erythromycin products. Mild symptoms may settle, but severe, persistent, or bloody diarrhoea requires prompt medical assessment.
Some combinations are unsafe. Erythromycin can interact with QT-prolonging heart medicines, certain statins, warfarin, calcium-channel blockers, anticonvulsants, and some herbal or supplement products that alter drug metabolism. The FDA label identifies major interaction pathways, while the 2023 WHO antibiotic guidance supports reviewing the full medicine list before prescribing. Do not add a new supplement during treatment without checking its active ingredients and interaction potential. A pharmacist can screen the complete list before the first dose.
Erythromycin may be used during pregnancy when the expected benefit of treating a bacterial infection outweighs the potential risks. The choice depends on the infection, pregnancy stage, formulation, and available alternatives. NHS and Medsafe information from 2022 describe passage into breast milk as possible, so an infant should be observed for diarrhoea, rash, or feeding changes. A prescriber should select the treatment plan for the specific infection rather than relying on a general rule.
Good hydration, regular meals when permitted for the formulation, and adequate rest can make treatment easier to tolerate. Alcohol does not treat infection and may worsen nausea or dehydration, while strenuous exercise may be unsuitable during fever or significant respiratory symptoms. The EMA's 2022 guidance advises following formulation-specific administration instructions because food can alter absorption for some erythromycin products. Avoid sharing pills, saving leftovers, or using antibiotics for a later illness.
Discuss previous macrolide allergy, liver disease, heart rhythm problems, fainting, low potassium, pregnancy, breastfeeding, and any previous severe diarrhoea after antibiotics. Provide a complete list of prescription medicines, non-prescription products, and supplements. Medsafe's 2022 prescribing information emphasises interaction review and attention to hepatic and cardiac risks. The clinician should also confirm that the suspected infection is bacterial and that erythromycin is suitable for the likely organism.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Erythromycin is available in several pharmaceutical forms, including immediate-release tablets, enteric-coated tablets, modified-release tablets, oral liquids, and injectable preparations. The pills sold on this page are intended for oral administration.
Different formulations cannot always be substituted tablet for tablet. Enteric coating can protect erythromycin from stomach acid and may alter absorption. A liquid formulation is measured differently from pills and is often selected when swallowing tablets is difficult or when a child needs weight-based dosing.
Brand names and presentations vary by country and supplier. The clinically relevant facts are the erythromycin formulation, strength, release characteristics, and prescribed schedule.
Based on 4 reviews
The sore throat settled after a few days, but the first doses caused nausea and stomach cramps. Eating a small meal helped me tolerate it, and the symptoms eased before the course ended.
Rotorua 4 Nov 2026The redness improved during the first week. I developed loose stools near the end, which continued briefly after the last pill. It was manageable, but I would not ignore persistent or bloody diarrhoea.
Whangārei 31 Oct 2026The medicine helped the facial pressure, though it made me feel queasy in the mornings. I found that taking doses at consistent times was easier than trying to fit them around meals.
Tauranga 16 Oct 2026The infection improved, but I had to review my regular medicines first because one of them could interact. The extra checking delayed the first dose slightly, yet it prevented an avoidable problem.
Wellington 9 Oct 2026
